Recently, the National Health and Medical Science and Technology Development Research Center of the National Health and Family Planning Commission announced the information on the key projects of the “Precision Medical Research†project to be entered into the review in 2016. At the same time, Precision Medical has been selected into the “13th Five-Year Plan†in 2016 and has risen to the national strategy. HSMAP has launched the "Investigation Company in the Field of Precision Medicine" to analyze the activity of investment institutions in the field of precision medicine and future investment trends.
Insight into global healthcare innovation and entrepreneurship practices
I. Decryption of investment institutions in the field of precision medicine in China
This paper has a total of 276 domestic medical investment companies (including 209 investment institutions and 67 industrial companies), with a total investment of 171. Based on the number of companies investing in precision medicine, we selected the top 25 companies from 276 investment companies and detailed statistics on their layout in various areas of precision medicine.
Note: Only disclosure items are included, and undisclosed items are not included in the statistics.
The above is the investment company TOP 5 in the field of precision medical treatment. Due to the limited layout, please check the “Top List†for the complete TOP 25. (If you have any questions about this ranking, please let us know in the message area at the bottom of the article, we will contact you as soon as possible.)
Interpretation 1: Beijing, Shanghai, Jiangsu, Guangdong are active areas for investment in precision medicine
There are a total of 171 domestic precision medical investment targets, which are distributed in gene sequencing , PCR, gene chip, liquid biopsy, cellular immunotherapy, antibody drugs and others (tumor big data, antibody related, accurate diagnosis, etc.).
From the geographical analysis of the invested projects combined with the top ten geographical distribution of China's precision medicine companies, Beijing, Shanghai, Jiangsu and Guangdong are active areas for precision medicine investment and financing.
Precision medicine is a systematic project, not only reflected in the precision medicine industry itself, but also has certain dependence on related industrial chains (including pharmaceuticals, in vitro diagnostic reagents, medical devices, etc.).
The areas cultivated by traditional medical enterprises have certain first-mover advantages in policy environment, enterprise channel construction, and personnel training. The precision medical industry environment is superior to other regions.
Interpretation 2: Accurate diagnosis is the focus of the layout of 25 investment companies
The above picture shows the precise areas of precision medicine of 25 investment companies. As can be seen from the figure, accurate diagnosis (including gene sequencing, PCR, gene chip, liquid biopsy) accounted for 64.03%.
Accurate diagnosis and detection are the basis of precision treatment. The industry starts earlier than precision treatment, and its supporting industrial chain is relatively mature in China.
A large number of in vitro diagnostic reagent companies have completed capital accumulation, channel layout and industry integration, and the policy is relatively mature. In terms of investment, there are relatively short periods and high returns, and investors can launch them faster.
Accurate treatment still has a large number of technical problems that have not been solved. The domestic research and development of innovative drugs and the policy environment and industrial chain support of producers are relatively immature.
In addition, its investment technology, policy risk is high, the cycle is relatively long, the professional requirements for investment are extremely high, and investment is relatively cautious.
Interpretation 3: The investment layout of precision medicine is beginning to emerge, and investment may become rational
.jpg)
As can be seen from the above two figures, in recent years, the number of companies established by precision medicine companies has been increasing over the years, and the investment layout is also in a hot trend.
Although the national precision medicine strategy has just been proposed, the industry and investment have begun to be laid out in recent years. Individual segments (PCR, gene chips, etc.) have already completed the early layout, and the industry has entered the integration period.
Medical investment, especially technology investment, is different from other industries. The understanding of technology is particularly demanding, and there are too many factors affecting the development of the medical industry .
Most investment institutions are relatively cautious about medical investment, especially when the policy is unclear and the medical technology trend is not fully verified. After a certain degree of heat in the project layout, it is an inevitable trend that investment tends to be rational.
Rabies Vaccine After Animal Bite
Rabies is a viral infection transmitted by saliva of infected mammals, most commonly wild, terrestrial carnivores (e.g., skunks, raccoons, foxes, coyotes) or bats.rabies virus usually moves along a neural pathway and enters the CNS. After entrance into the CNS, the virus is unlikely to be affected by antirabies antibodies and encephalomyelitis usually develops and almost always is fatal. Vaccination of rabies vaccine in a timely manner is mandatory.
Rabies Vaccine After Animal Bite,Animal Bite Rabies Vaccine,Freeze Animal Bite Rabies Vaccine,Freeze Rabies Vaccine After Animal Bite
Changchun Zhuoyi Biological Co., Ltd , https://www.zhuoyi-bio.com